Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Dopaminergic Denervation by DaTSCAN Brain Scintigraphy Using a New Multipurpose CZT System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients referred to our Nuclear Medicine department for DaTSCAN scintigraphy.~Exclusion Criteria:~* Under 18 years-old patients.~* Pregnant women or at risk of pregnancy.~* Breast feeding.~* Painful patients.~* Patients under guardianship.~* Patients in whom a standard examination is not feasible (agitation).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DaTSCAN brain scan images from the new CZT SPECT system (Type: EXPERIMENTAL): All patients will undergo additional SPECT acquisition (30min added time approximately), with no added radiation, with both new multipurpose CZT camera (StarGuide system, GE Healthcare, Haïfa, Israel) and conventional SPECT camera (Discovery 670, GE Healthcare, Haïfa, Israel)

Based on this trial design, predict the completion outcome and termination type (if applicable).